col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Russian Dialysis Society

16 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Nephrology and Dialysis 2023―Apr―07 COVID-19 in patients with advanced stages of diabetic kidney disease: new onset renal replacement therapy as one of the predictors of adverse outcome N.N. Klochkova, M.A. Lysenko, E.M. Zeltyn-Abramov, T.N. Markova, N.G. Poteshkina, N.I. Belavina, S.V. Kondrashkina
2 [GO] Nephrology and Dialysis 2023―Jan―04 Features of COVID-19 vaccine prophylaxis in renal graft recipients I.G. Kim, L.I. Novikova, N.F. Frolova, E.V. Volodina, C.C. Bochkareva, V.E. Vinogradov, et al. (+6)
3 [GO] Nephrology and Dialysis 2022―Oct―18 Associations of renal dysfunction and hyperuricemia in patients with a new coronavirus infection A.D. Khudyakova, A.P. Kashirina, A.A. Karaseva, E.V. Stryukova, I.I. Logvinenko
4 [GO] Nephrology and Dialysis 2022―Aug―01 COVID-19 and virus-associated skin diseases in patients after kidney transplantation I.N. Dymkov, A.D. Perlina, I.V. Terentiev, E.I. Prokopenko, P.A. Kulikov, D.V. Perlin
5 [GO] Nephrology and Dialysis 2022―Aug―01 The use of therapeutic plasma exchange in the severe forms of COVID-19 in patients with renal fаilure N.F. Frolova, N.A. Tomilina, K.E. Loss, E.S. Stolyarevich, R.T. Iskhakov, G.N. Arbolishvili, et al. (+8)
6 [GO] Nephrology and Dialysis 2022―Aug―01 The management of medical care with dialysis methods in outpatients during the COVID-19 pandemic A.P. Ilyin, K.Ya. Gurevich, A.Yu. Denisov, E.M. Shilov, M.M. Shilova, N.A. Brygina, O.A. Kodyusheva
7 [GO] Nephrology and Dialysis 2022―Aug―01 The modern concept of etiology, pathogenesis, the role of anticytokine therapy and methods of extracorporeal treatment for new coronavirus infection (SARS-CoV-2). Review S.V. Masolitin, T.G. Kim, A.V. Yaralian, E.Y. Kalinin, D.V. Losev
8 [GO] Nephrology and Dialysis 2022―Jan―17 Novel coronavirus infection and hemodialysis: course and predictors of unfavorable outcome M.L. Zubkin, I.G. Kim, N.F. Frolova, A.I. Ushakova, S.S. Usatiuk, R.T. Iskhakov, et al. (+7)
9 [GO] Nephrology and Dialysis 2021―Sep―30 Mechanisms of acute kidney injury in Covid-19. Review L.D. Maltseva, I.M. Vasalatii, Y.A. Isaakyan, O.L. Morozova
10 [GO] Nephrology and Dialysis 2021―Jun―30 Covid-19: relationship with kidney diseases. Literature review N.A. Tomilina, N.F. Frolova, L.Yu. Artyukhina, S.S. Usatyuk, T.A. Buruleva, E.N. Djakova, et al. (+5)
11 [GO] Nephrology and Dialysis 2021―Jun―30 SARS-CoV-2 infection in kidney transplant recipients I.G. Kim, L.Yu. Artyukhina, N.F. Frolova, E.S. Ivanova, I.V. Ostrovskaya, V.A. Berdinsky, et al. (+11)
12 [GO] Nephrology and Dialysis 2020―Oct―28 Kidney damage in Covid-19: clinical and morphological manifestations of renal pathology in 220 patients died from Covid-19 E.S. Stolyarevich, N.F. Frolova, L.Y. Artyukhina, V.V. Varyasin
13 [GO] Nephrology and Dialysis 2020―Oct―28 Eсulizumab in treatment of ANCA-associated vasculitis complicated with Covid-19. Clinical observations N.F. Frolova, N.A. Tomilina, O.N. Kotenko, O.L. Podkorytova, R.T. Ishakov, S.S. Usatyuk, et al. (+5)
14 [GO] Nephrology and Dialysis 2020―Oct―28 Risk factors of adverse prognosis in patients on maintenance hemodialysis with Covid-19. Focus on cardivascular comorbidity. Single center experience E.M. Zeltyn-Abramov, N.I. Belavina, N.F. Frolova, A.I. Ushakova, N.N. Klochkova, N.V. Sokolova, et al. (+4)
15 [GO] Nephrology and Dialysis 2020―Oct―28 Covid-19-associated cardiac damage in patients on maintenance hemodialysis. Case reports and review of the literature E.M. Zeltyn-Abramov, N.I. Belavina, N.F. Frolova, V.V. Varyasin, O.Y. Evsyukov, O.V. Manchenko, et al. (+4)
16 [GO] Nephrology and Dialysis 2020―Jun―16 Ensuring optimal care for people with kidney disease during the COVID-19 pandemic Anupam Agarwal, Carmine Zoccali, Vivekanand Jha
 [1] 

16 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec